Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Infinity Pharmaceuticals Inc (NASDAQ:INFI)

2.70
Delayed Data
As of Oct 17
 -0.25 / -8.47%
Today’s Change
0.84
Today|||52-Week Range
3.84
+100.00%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Biotechnology
MARKET CAP
$149.5M

Company Description

Infinity Pharmaceuticals, Inc. is an innovative biopharmaceutical company, which engages in discovering, developing and delivering medicines for people with cancer. The company was founded by Steven H. Holtzman on March 22, 1995 and is headquartered in Cambridge, MA.

Contact Information

Infinity Pharmaceuticals, Inc.
784 Memorial Drive
Cambridge Massachusetts 02139
P:(617) 453-1000
Investor Relations:
(617) 453-1336

Employees

Shareholders

Other institutional47.42%
Individual stakeholders39.03%
Mutual fund holders22.50%

Top Executives

Adelene Q. PerkinsChairman & Chief Executive Officer
Lawrence E. BlochPresident & Treasurer
Jeffery KutokChief Scientific Officer & Senior Vice President
Claudio Dansky UllmannSenior Vice President-Clinical Development
Seth TaskerSecretary, Vice President & General Counsel